This is good news.... Maybe the detail is in what the doctor said. Direct injections = 80% healing rate, which is rather high !
They have been using these cells for a while in hospitals in Australia with success too, so I wouldn't say necessarily that the IV route failed to have an effect...
What they may find, with direct injection they may get away with significantly less cells needed = lower cost of therapy = more competitive.
Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis, page-50
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.07 |
Change
0.150(5.14%) |
Mkt cap ! $3.836B | |||
| Open | High | Low | Value | Volume |
| $2.98 | $3.07 | $2.93 | $11.37M | 3.808M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 24256 | $3.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.07 | 42689 | 14 |
View Market Depth
| Last trade - 14.04pm 07/02/2025 (20 minute delay) ? |
| MSB (ASX) Chart |